{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:02:14Z","timestamp":1776718934640,"version":"3.51.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA139596"],"award-info":[{"award-number":["CA139596"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA171436"],"award-info":[{"award-number":["CA171436"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","award":["Lilly USA Research Award in Cancer Prevention and Early Detection"],"award-info":[{"award-number":["Lilly USA Research Award in Cancer Prevention and Early Detection"]}],"id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UIC College of Dentistry","award":["CMBOD Oral Cancer Research Program - seed grant"],"award-info":[{"award-number":["CMBOD Oral Cancer Research Program - seed grant"]}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC81472523"],"award-info":[{"award-number":["NSFC81472523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC81272953"],"award-info":[{"award-number":["NSFC81272953"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE025926"],"award-info":[{"award-number":["DE025926"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2716-0","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T16:02:36Z","timestamp":1472140956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Qianting","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zujian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Koya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghong","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Cabay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"2716_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0002-9610(05)80333-2","volume":"166","author":"D Franceschi","year":"1993","unstructured":"Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg. 1993;166:360\u20135.","journal-title":"Am J Surg"},{"key":"2716_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/(SICI)1097-0347(199701)19:1<14::AID-HED3>3.0.CO;2-Y","volume":"19","author":"RM Byers","year":"1997","unstructured":"Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of \u201cskip metastases\u201d in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997;19:14\u20139.","journal-title":"Head Neck"},{"key":"2716_CR3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/archotol.128.7.751","volume":"128","author":"KT Robbins","year":"2002","unstructured":"Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, Som P, et al. Neck dissection classification update: revisions proposed by the American head and neck society and the American academy of otolaryngology-head and neck surgery. Arch Otolaryngol Head Neck Surg. 2002;128:751\u20138.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2716_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0002-9610(89)90122-0","volume":"158","author":"AR Fakih","year":"1989","unstructured":"Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989;158:309\u201313.","journal-title":"Am J Surg"},{"key":"2716_CR5","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1158\/1078-0432.CCR-07-0666","volume":"14","author":"TS Wong","year":"2008","unstructured":"Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14:2588\u201392.","journal-title":"Clin Cancer Res"},{"key":"2716_CR6","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-07-5194","volume":"68","author":"K Kozaki","year":"2008","unstructured":"Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008;68:2094\u2013105.","journal-title":"Cancer Res"},{"key":"2716_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbrc.2007.03.201","volume":"358","author":"N Tran","year":"2007","unstructured":"Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'Brien C, Rose B. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun. 2007;358:12\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2716_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-4598-6-5","volume":"6","author":"C Hebert","year":"2007","unstructured":"Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer. 2007;6:5.","journal-title":"Mol Cancer"},{"key":"2716_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-62703-083-0_10","volume":"936","author":"Y Jin","year":"2012","unstructured":"Jin Y, Chen Z, Liu X, Zhou X. Evaluating the microRNA targeting sites by luciferase reporter gene assay. Methods Mol Biol. 2012;936:117\u201327.","journal-title":"Methods Mol Biol"},{"key":"2716_CR10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3892\/or.2014.3456","volume":"32","author":"Z Sun","year":"2014","unstructured":"Sun Z, Li S, Kaufmann AM, Albers AE. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines. Oncol Rep. 2014;32:2283\u20139.","journal-title":"Oncol Rep"},{"key":"2716_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1201\/EBK1439814888-c2","volume":"2","author":"Y Dai","year":"2010","unstructured":"Dai Y, Zhou X. Computational methods for the identification of microRNA targets. Open Access Bioinformatics. 2010;2:29\u201339.","journal-title":"Open Access Bioinformatics"},{"key":"2716_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03315","volume":"433","author":"LP Lim","year":"2005","unstructured":"Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769\u201373.","journal-title":"Nature"},{"key":"2716_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00439-010-0915-3","volume":"129","author":"L Jiang","year":"2011","unstructured":"Jiang L, Dai Y, Liu X, Wang C, Wang A, Chen Z, Heidbreder CE, et al. Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Hum Genet. 2011;129:189\u201397.","journal-title":"Hum Genet"},{"key":"2716_CR14","doi-asserted-by":"publisher","first-page":"e80625","DOI":"10.1371\/journal.pone.0080625","volume":"8","author":"D Chen","year":"2013","unstructured":"Chen D, Chen Z, Jin Y, Dragas D, Zhang L, Adjei BS, Wang A, et al. MicroRNA-99 family members suppress homeobox A1 expression in epithelial cells. PLoS One. 2013;8:e80625.","journal-title":"PLoS One"},{"key":"2716_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2164-9-69","volume":"9","author":"H Ye","year":"2008","unstructured":"Ye H, Yu T, Temam S, Ziober BL, Wang J, Schwartz JL, Mao L, et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics. 2008;9:69.","journal-title":"BMC Genomics"},{"key":"2716_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.oraloncology.2012.02.020","volume":"48","author":"Z Chen","year":"2012","unstructured":"Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, Wang C, Liu X, et al. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol. 2012;48:686\u201391.","journal-title":"Oral Oncol"},{"key":"2716_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N. miRWalk--database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J Biomed Inform. 2011;44:839\u201347.","journal-title":"J Biomed Inform"},{"key":"2716_CR18","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kruger","year":"2006","unstructured":"Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006;34:W451\u20134.","journal-title":"Nucleic Acids Res"},{"key":"2716_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/hed.10344","volume":"26","author":"VB Wreesmann","year":"2004","unstructured":"Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, Schnaser EA, Sacks PG, et al. Genetic abnormalities associated with nodal metastasis in head and neck cancer. Head Neck. 2004;26:10\u20135.","journal-title":"Head Neck"},{"key":"2716_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1368-8375(03)00038-1","volume":"39","author":"N Vigneswaran","year":"2003","unstructured":"Vigneswaran N, Wu J, Zacharias W. Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. Oral Oncol. 2003;39:559\u201368.","journal-title":"Oral Oncol"},{"key":"2716_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/0277-5379(88)90335-5","volume":"24","author":"J Gioanni","year":"1988","unstructured":"Gioanni J, Fischel JL, Lambert JC, Demard F, Mazeau C, Zanghellini E, Ettore F, et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol. 1988;24:1445\u201355.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2716_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/archotol.1981.00790470051012","volume":"107","author":"CJ Krause","year":"1981","unstructured":"Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD, Regezi JA. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol. 1981;107:703\u201310.","journal-title":"Arch Otolaryngol"},{"key":"2716_CR23","first-page":"1657","volume":"41","author":"JG Rheinwald","year":"1981","unstructured":"Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 1981;41:1657\u201363.","journal-title":"Cancer Res"},{"key":"2716_CR24","first-page":"97","volume":"3","author":"RG He","year":"1983","unstructured":"He RG, Xu X, Zhou X, Zhang X, Qiu W, Zhang X, Liu A, et al. The establishment and some biological characteristics of a squamous cell cancer cell line of the human tongue (Tca8113). Ai Zheng. 1983;3:97\u2013100.","journal-title":"Ai Zheng"},{"key":"2716_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000024515","volume":"18","author":"S Nakayama","year":"1998","unstructured":"Nakayama S, Sasaki A, Mese H, Alcalde RE, Matsumura T. Establishment of high and low metastasis cell lines derived from a human tongue squamous cell carcinoma. Invasion Metastasis. 1998;18:219\u201328.","journal-title":"Invasion Metastasis"},{"key":"2716_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ijc.25320","volume":"127","author":"L Jiang","year":"2010","unstructured":"Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, Shi F, et al. Down-regulation of the Rho GTPase signaling pathway is involved in the microRNA-138 mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer. 2010;127:505\u201312.","journal-title":"Int J Cancer"},{"key":"2716_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.canlet.2009.05.030","volume":"286","author":"X Liu","year":"2009","unstructured":"Liu X, Jiang L, Wang A, Yu J, Shi F, Zhou X. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett. 2009;286:217\u201322.","journal-title":"Cancer Lett"},{"key":"2716_CR28","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1016\/j.febslet.2010.08.040","volume":"584","author":"X Liu","year":"2010","unstructured":"Liu X, Wang A, Heidbreder CE, Jiang L, Yu J, Kolokythas A, Huang L, et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Lett. 2010;584:4115\u201320.","journal-title":"FEBS Lett"},{"key":"2716_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1600-0714.2007.00596.x","volume":"37","author":"JL Schwartz","year":"2008","unstructured":"Schwartz JL, Panda S, Beam C, Bach LE, Adami GR. RNA from brush oral cytology to measure squamous cell carcinoma gene expression. J Oral Pathol Med. 2008;37:70\u20137.","journal-title":"J Oral Pathol Med"},{"key":"2716_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.oraloncology.2011.03.029","volume":"47","author":"A Kolokythas","year":"2011","unstructured":"Kolokythas A, Schwartz JL, Pytynia KB, Panda S, Yao M, Homann B, Sroussi HY, et al. Analysis of RNA from brush cytology detects changes in B2M, CYP1B1 and KRT17 levels with OSCC in tobacco users. Oral Oncol. 2011;47:532\u20136.","journal-title":"Oral Oncol"},{"key":"2716_CR31","doi-asserted-by":"publisher","first-page":"e64434","DOI":"10.1371\/journal.pone.0064434","volume":"8","author":"Y Jin","year":"2013","unstructured":"Jin Y, Tymen SD, Chen D, Fang ZJ, Zhao Y, Dragas D, Dai Y, et al. MicroRNA-99 Family Targets AKT\/mTOR Signaling Pathway in Dermal Wound Healing. PLoS One. 2013;8:e64434.","journal-title":"PLoS One"},{"key":"2716_CR32","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1158\/1078-0432.CCR-08-3053","volume":"15","author":"J Li","year":"2009","unstructured":"Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009;15:3998\u20134008.","journal-title":"Clin Cancer Res"},{"key":"2716_CR33","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3892\/or.2014.3334","volume":"32","author":"M Qian","year":"2014","unstructured":"Qian M, Qian D, Jing H, Li Y, Ma C, Zhou Y. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo. Oncol Rep. 2014;32:1681\u20138.","journal-title":"Oncol Rep"},{"key":"2716_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.oraloncology.2010.09.005","volume":"46","author":"AC Abrahao","year":"2010","unstructured":"Abrahao AC, Castilho RM, Squarize CH, Molinolo AA, dos Santos-Pinto Jr D, Gutkind JS. A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation. Oral Onco. 2010;46:880\u20137.","journal-title":"Oral Onco"},{"key":"2716_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1541-7786.MCR-13-0419","volume":"12","author":"L Lu","year":"2014","unstructured":"Lu L, Byrnes K, Han C, Wang Y, Wu T. miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth. Mol Cancer Res. 2014;12:890\u2013900.","journal-title":"Mol Cancer Res"},{"key":"2716_CR36","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1038\/sj.onc.1204591","volume":"20","author":"MG Seidel","year":"2001","unstructured":"Seidel MG, Look AT. E2A-HLF usurps control of evolutionarily conserved survival pathways. Oncogene. 2001;20:5718\u201325.","journal-title":"Oncogene"},{"key":"2716_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30:377\u201386.","journal-title":"Carcinogenesis"},{"key":"2716_CR38","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.5037\/jomr.2013.4102","volume":"4","author":"D Chen","year":"2013","unstructured":"Chen D, Cabay RJ, Jin Y, Wang A, Lu Y, Shah-Khan M, Zhou X. MicroRNA deregulations in head and neck squamous cell carcinomas. J Oral Maxillofac Res. 2013;4:e2.","journal-title":"J Oral Maxillofac Res"},{"key":"2716_CR39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/his.12258","volume":"64","author":"Z Feng","year":"2014","unstructured":"Feng Z, Li JN, Wang L, Pu YF, Wang Y, Guo CB. The prognostic value of glycerol-3-phosphate dehydrogenase 1-like expression in head and neck squamous cell carcinoma. Histopathology. 2014;64:348\u201355.","journal-title":"Histopathology"},{"key":"2716_CR40","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/MCB.01242-10","volume":"31","author":"TJ Kelly","year":"2011","unstructured":"Kelly TJ, Souza AL, Clish CB, Puigserver P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol. 2011;31:2696\u2013706.","journal-title":"Mol Cell Biol"},{"key":"2716_CR41","first-page":"1256","volume":"2012","author":"C Cadenas","year":"1821","unstructured":"Cadenas C, Vosbeck S, Hein EM, Hellwig B, Langer A, Hayen H, Franckenstein D, et al. Glycerophospholipid profile in oncogene-induced senescence. Biochim Biophys Acta. 1821;2012:1256\u201368.","journal-title":"Biochim Biophys Acta"},{"key":"2716_CR42","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1038\/onc.2013.283","volume":"33","author":"GG Galli","year":"2014","unstructured":"Galli GG, Multhaupt HA, Carrara M, de Lichtenberg KH, Christensen IB, Linnemann D, Santoni-Rugiu E, et al. Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression. Oncogene. 2014;33:3342\u201350.","journal-title":"Oncogene"},{"key":"2716_CR43","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1101\/gad.6.9.1608","volume":"6","author":"SP Hunger","year":"1992","unstructured":"Hunger SP, Ohyashiki K, Toyama K, Cleary ML. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 1992;6:1608\u201320.","journal-title":"Genes Dev"},{"key":"2716_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.1386162","volume":"257","author":"T Inaba","year":"1992","unstructured":"Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science. 1992;257:531\u20134.","journal-title":"Science"},{"key":"2716_CR45","doi-asserted-by":"publisher","first-page":"e0133663","DOI":"10.1371\/journal.pone.0133663","volume":"10","author":"Y Kita","year":"2015","unstructured":"Kita Y, Yoshida K, Tokuoka SM, Hamano F, Yamazaki M, Sakimura K, Kano M, et al. Fever is mediated by conversion of endocannabinoid 2-arachidonoylglycerol to prostaglandin E2. PLoS One. 2015;10:e0133663.","journal-title":"PLoS One"},{"key":"2716_CR46","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.chembiol.2011.05.009","volume":"18","author":"DK Nomura","year":"2011","unstructured":"Nomura DK, Lombardi DP, Chang JW, Niessen S, Ward AM, Long JZ, Hoover HH, et al. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem Biol. 2011;18:846\u201356.","journal-title":"Chem Biol"},{"key":"2716_CR47","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1074\/jbc.M411221200","volume":"280","author":"MG Backlund","year":"2005","unstructured":"Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES, Milne GL, et al. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem. 2005;280:3217\u201323.","journal-title":"J Biol Chem"},{"key":"2716_CR48","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1158\/0008-5472.CAN-05-4368","volume":"66","author":"I Wolf","year":"2006","unstructured":"Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, et al. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res. 2006;66:7818\u201323.","journal-title":"Cancer Res"},{"key":"2716_CR49","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1158\/1078-0432.CCR-08-2518","volume":"15","author":"A Thiel","year":"2009","unstructured":"Thiel A, Ganesan A, Mrena J, Junnila S, Nykanen A, Hemmes A, Tai HH, et al. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clin Cancer Res. 2009;15:4572\u201380.","journal-title":"Clin Cancer Res"},{"key":"2716_CR50","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.1158\/0008-5472.CAN-08-2893","volume":"68","author":"MG Backlund","year":"2008","unstructured":"Backlund MG, Mann JR, Holla VR, Shi Q, Daikoku T, Dey SK, DuBois RN. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer. Cancer Res. 2008;68:9331\u20137.","journal-title":"Cancer Res"},{"key":"2716_CR51","doi-asserted-by":"publisher","first-page":"12098","DOI":"10.1073\/pnas.0603235103","volume":"103","author":"SJ Myung","year":"2006","unstructured":"Myung SJ, Rerko RM, Yan M, Platzer P, Guda K, Dotson A, Lawrence E, et al. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci U S A. 2006;103:12098\u2013102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2716_CR52","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2353\/ajpath.2010.090875","volume":"176","author":"S Tseng-Rogenski","year":"2010","unstructured":"Tseng-Rogenski S, Gee J, Ignatoski KW, Kunju LP, Bucheit A, Kintner HJ, Morris D, et al. Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression. Am J Pathol. 2010;176:1462\u20138.","journal-title":"Am J Pathol"},{"key":"2716_CR53","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1349-7006.2009.01390.x","volume":"101","author":"H Tatsuwaki","year":"2010","unstructured":"Tatsuwaki H, Tanigawa T, Watanabe T, Machida H, Okazaki H, Yamagami H, Shiba M, et al. Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma. Cancer Sci. 2010;101:550\u20138.","journal-title":"Cancer Sci"},{"key":"2716_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.oraloncology.2015.01.008","volume":"51","author":"Z Jamali","year":"2015","unstructured":"Jamali Z, Asl Aminabadi N, Attaran R, Pournagiazar F, Ghertasi Oskouei S, Ahmadpour F. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol. 2015;51:321\u201331.","journal-title":"Oral Oncol"},{"key":"2716_CR55","doi-asserted-by":"publisher","first-page":"40104","DOI":"10.1074\/jbc.C111.296707","volume":"286","author":"Y Jin","year":"2011","unstructured":"Jin Y, Wang C, Liu X, Mu W, Chen Z, Yu D, Wang A, et al. Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem. 2011;286:40104\u20139.","journal-title":"J Biol Chem"},{"key":"2716_CR56","doi-asserted-by":"publisher","first-page":"35451","DOI":"10.1074\/jbc.M302474200","volume":"278","author":"FG Buchanan","year":"2003","unstructured":"Buchanan FG, Wang D, Bargiacchi F, DuBois RN. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem. 2003;278:35451\u20137.","journal-title":"J Biol Chem"},{"key":"2716_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1535-6108(03)00310-6","volume":"4","author":"AJ Dannenberg","year":"2003","unstructured":"Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell. 2003;4:431\u20136.","journal-title":"Cancer Cell"},{"key":"2716_CR58","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000084996","volume":"67","author":"R Schuon","year":"2005","unstructured":"Schuon R, Brieger J, Franke RL, Jakob R, Mann WJ. Increased PGE2 levels in nonmalignant mucosa adjacent to squamous cell carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec. 2005;67:96\u2013100.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"2716_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hed.2880170206","volume":"17","author":"CH Snyderman","year":"1995","unstructured":"Snyderman CH, Milanovich M, Wagner RL, Johnson JT. Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients. Head Neck. 1995;17:108\u201313.","journal-title":"Head Neck"},{"key":"2716_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10:181\u201393.","journal-title":"Nat Rev Cancer"},{"key":"2716_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10555-011-9314-z","volume":"30","author":"HH Tai","year":"2011","unstructured":"Tai HH. Prostaglandin catabolic enzymes as tumor suppressors. Cancer Metastasis Rev. 2011;30:409\u201317.","journal-title":"Cancer Metastasis Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2716-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2716-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2716-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2716-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T13:02:27Z","timestamp":1589461347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2716-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2716"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2716-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]},"assertion":[{"value":"14 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"685"}}